1.
Anti-IL5 therapy is associated with attenuated lung function decline in severe eosinophilic asthma patients from the Belgian Severe Asthma Registry.
2.
3.
4.
5.
6.
Reducing Tolerance for SABA and OCS towards the Extreme Ends of Asthma Severity
Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR).
Une décennie d’avancées dans l’asthme : l’apport des biothérapies. ; Asthma : the contribution of biotherapies